Search
for
Sort by
Research 30 of 1000+
- Therapeutic Response of Alopecia Areata‐Associated Nail Changes to Baricitinib
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Telecommunication in the COVID-19 era: As an assessment tool for patients with dermatomyositis
- British Hair and Nail Society
- Periungual lesions secondary to chemotherapy with docetaxel
- THERAPEUTIC CHALLENGES IN POLYAUTOIMMUNITY: ANIFROLUMAB FOR LUPUS ERYTHEMATODES IN OVERLAPPING AUTOIMMUNE SYNDROMES
- Abstract 2469: Increased cathepsin B expression in cultured tuberous sclerosis skin tumor cells and patient tumor tissues
- Case report: pemphigus vulgaris in an adolescent
- Malignancy and Cancer Treatment-Related Hair and Nail Changes
- Mucocutaneous reactions to chemotherapy
- Cutaneous manifestations of the COVID-19 pandemic in schoolchildren and adolescents
- Dermatologic Side Effects of Systemic Targeted Anticancer Therapy
- Skin
- Semiology of skin toxicity associated with epidermal growth factor receptor (EGFR) inhibitors
- Drug-Induced Skin, Nail and Hair Disorders
- Dermatological adverse events with taxane chemotherapy
- Alopecia areata: Clinical presentation, diagnosis, and unusual cases
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Dermatologic Reactions to Targeted Therapy
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- STUDY OF CUTANEOUS MANIFESTATIONS IN THYROID DISORDERS
- Dermatological drugs, topical agents, and cosmetics
- Clinical review 74: Dermatological manifestations of endocrine disorders.
- Skin disease in pregnancy
- The Skin and Subcutaneous Tissues
- Dermoscopic Assessment of Nail Alterations in Egyptian Patients with Alopecia Areata
- Human TSC2-null fibroblast-like cells induce hair follicle neogenesis and hamartoma morphogenesis
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Dermatologic Adverse Events from Cancer Treatments